Guided Therapeutics Inc  

(Public, OTCBB:GTHP)   Watch this stock  
Find more results for OTC:GTHP
+0.0011 (4.60%)
May 24 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.02 - 0.03
52 week 0.02 - 14.90
Open 0.02
Vol / Avg. 714,263.00/583,842.00
Mkt cap 714,150.00
P/E     -
Div/yield     -
EPS -7.20
Shares 29.88M
Beta 0.14
Inst. own 0%
Aug 10, 2016
Q2 2016 Guided Therapeutics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 18, 2016
Q1 2016 Guided Therapeutics Inc Earnings Release
Mar 15, 2016
Q4 2015 Guided Therapeutics Inc Earnings Call
Mar 14, 2016
Q4 2015 Guided Therapeutics Inc Earnings Release

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -703.20% -1138.94%
Operating margin -617.60% -1027.56%
EBITD margin - -853.63%
Return on average assets -264.59% -246.76%
Return on average equity - -
Employees 33 -
CDP Score - -


5835 Peachtree Cors E Ste D
NORCROSS, GA 30092-3413
United States - Map
+1-770-2428723 (Phone)
+1-770-2428639 (Fax)

Website links


Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.

Officers and directors

Michael C. James Independent Chairman and Director
Age: 57
Gene S. Cartwright Ph.D. Chief Executive Officer, Acting Chief Financial Officer, President and Director
Age: 61
Richard L. Fowler Senior Vice President - Engineering
Age: 58
John E. Imhoff M.D. Independent Director
Age: 66
Jonathan M. Niloff M.D. Independent Director
Age: 62
Linda M. Rosenstock M.D. Independent Director
Age: 65